Vicore Pharma Holding
Vicore Pharma: Smart Money Injection (Redeye)

2020-07-03 08:49
Redeye has a positive view on Vicore’s directed share issue of SEK 185 million to Swedish institutional investors. Although the issue causes a dilution effect, it has also increased out confidence in the case. Hence, we see no reason to adjust our fair values at this point, and we reiterate our Base case at SEK 48 per share.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Vicore Pharma Holding - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -